by EpicentRx | Mar 21, 2023 | Media
by EpicentRx | Mar 21, 2023 | 2023, Press Releases
RRx-001 is a small molecule direct NLRP3 inflammasome inhibitor with activity in cancer, neurodegeneration, and other inflammatory conditions RRx-001 is the most advanced direct NLRP3 inflammasome inhibitor in clinical development, having been evaluated in over 300...
by EpicentRx | Mar 20, 2023 | Meet The Team
Elena’s preferences (lightning round) Quality vs quantity? “Quality of course” Chicken wings or Chicken Kyiv? “Chicken wings” San Diego or Chicago? “San Diego” EpicentRx or anywhere else? “EpicentRx. By far. No other...
by EpicentRx | Mar 20, 2023 | Meet The Team
The list of Iranians living in America who have done great things is long and includes Pierre Omidyar, founder of eBay, Isaac Larian, the founder, and CEO of MGA entertainment, Salar Kamangar, a senior executive at Google and a former CEO of YouTube, Manny Mashouf,...
by EpicentRx | Mar 15, 2023 | Conferences
March 2023, Gothenburg Sweden Oral Presentation: RRx-001, A Direct NLRP3 Inhibitor and Phase 3 Small Molecule Improves Alzheimer’s and Parkinson’s Pathology in Multiple Disease Models
